Publications

STING agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastoma

Download PDF
Resource: STING agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastoma

.

Related Articles

Super-enhancer hijacking drives ectopic expression of hedgehog pathway ligands in meningiomas

Link
Spatial omics techniques and data analysis for cancer immunotherapy applications

Link